Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
21
|
pubmed:dateCreated |
1992-11-25
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
327
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1531-2
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1406889-Aged,
pubmed-meshheading:1406889-Body Mass Index,
pubmed-meshheading:1406889-Cerebrovascular Disorders,
pubmed-meshheading:1406889-Humans,
pubmed-meshheading:1406889-Risk,
pubmed-meshheading:1406889-Streptokinase,
pubmed-meshheading:1406889-Thrombolytic Therapy,
pubmed-meshheading:1406889-Tissue Plasminogen Activator
|
pubmed:year |
1992
|
pubmed:articleTitle |
The risk of stroke after thrombolytic therapy.
|
pubmed:publicationType |
Letter,
Comparative Study,
Comment
|